The Blind Side
In American football, most quarterbacks are right-handed. So, when they drop back to pass, they typically turn their backs to the left side of the line of scrimmage. They are essentially blind to what happens behind them. If the offensive line is weak, the quarterback is vulnerable to a potentially devastating hit, risking not only that particular play but also possession of the ball and possibly serious injury.
The critical merits of having a solid risk control process – putting the strongest offensive linemen on the left side, were highlighted in the movie, The Blind Side.
Like football, investing carries considerable risk of (financial) injury and thus requires sensible risk control. Our investment selection process focuses on the company-specific level: the condition and direction of the company’s fundamentals and its share valuation. We readily accept these risks and exert considerable effort to make sure we get the fundamentals and valuation right. In many ways, this is similar to the task of the quarterback – they focus on executing their particular job which often is making a good pass to the receiver.
The most dangerous risk is the one that you don’t see coming. Just like the quarterback getting blindsided by an unseen lineman taking them down from behind, investors can be blindsided by unseen risks. So, our risk management process focuses on identifying these risks. By scanning the horizon for all kinds of risks, almost regardless of their likelihood, we can think about the risks and how to mitigate or avoid them. We call this being “macro aware.”
For us, non-company-specific risks might include the economy, financial markets, interest rates, currencies, commodities, geopolitical, societal and others. Our current roster includes over 20 different macro risks. The hurdle for inclusion on this roster is relatively low: a risk needs to be somewhat unique relative to other risks already on the list, and it needs to be reasonably relevant to our investing. We believe it is better to list too many than too few.
Once identified, the next step is to monitor the magnitude of the risk and the direction of that risk (is it increasing or decreasing). The magnitude part is obvious – it tells us how much the risk is driving or will drive the investing environment we are currently in. The direction is just as important: it tells us whether we should become more, or less, worried.
Subtly, but incredibly valuably, this last part frees us from spending too much time assessing a risk. We can’t hope to accurately evaluate the risk of the U.S federal government running out of money, for example, but we can readily assess whether it is becoming a bigger, or smaller, risk (answer: bigger).
By following this simple and time-efficient process, we hope to reduce our chance of being blindsided. And that could help produce an ending as happy as that in the movie.
Share prices in the table reflect Tuesday (August 30) closing prices. Please note that prices in the discussion below are based on mid-day August 30 prices.
Note to new subscribers: You can find additional color on our thesis, recent earnings reports and other news on recommended companies in prior editions of the Cabot Undervalued Stocks Advisor, particularly the monthly edition, on the Cabot website.
Send questions and comments to Bruce@CabotWealth.com.
Today’s Portfolio Changes
New Buy: Gates Industrial Corporation plc (GTES)
Last Week’s Portfolio Changes
The Cola-Cola Company (KO) – Moving from Hold to Sell.
Growth/Income Portfolio
Cisco Systems (CSCO) is facing revenue pressure as customers migrate to the cloud and thus need less of Cisco’s equipment and one-stop-shop services. Cisco’s prospects are starting to improve under a relatively new CEO, who is shifting Cisco toward a software and subscription model and is rolling out new products, helped by its strong reputation and entrenched position within its customers’ infrastructure. The company is highly profitable, generates vast cash flow (which it returns to shareholders through dividends and buybacks) and has a very strong balance sheet.
On August 17, Cisco reported adjusted fiscal fourth-quarter earnings of $0.83/share, down 1% from a year ago but 1% above the consensus estimate. Revenues were flat but were about 2% above consensus. Going into the report, market sentiment on Cisco shares was pessimistic, so the above-consensus results provided enough encouragement that the shares jumped about 6% on the news. We remain on board with the Cisco position.
Cisco is grinding through the secular and near-term supply chain and other headwinds, supported by resilient yet flattish demand for its products and services. The company will likely continue to show modest revenue growth. Guidance for fiscal 2023 is for 2-4% growth, about the same pace as this past year, which seems reasonable to us. Cisco is showing its cash generation powers with its nearly $4 billion in combined dividends and share repurchases in the quarter. For the year, the company returned $14 billion to shareholders (about 7% of its market value). Since a year ago, the share count is down 2.4%. The balance sheet has $9.8 billion in cash in excess of debt – this is about $3 billion lower than a year ago as Cisco used some of its cash for dividends and buybacks. We’re fine with this use of excess cash. We also note, encouragingly, that Cisco seems to be slowing its pace of acquisitions, which not only conserves cash and shares but also shows that the company can increase revenues organically without relying on “buying” revenues through acquisitions.
Cisco added Sarah Rae Murphy to its board of directors. Murphy served with United Airlines for 16 years, most recently as head of global procurement and sourcing. She also has earlier experience as an investment banking analyst with Merrill Lynch. Her experience provides board-level expertise in supply chain oversight.
CSCO shares fell 5% in the past week in a sloppy market and have 46% upside to our 66 price target. The valuation is attractive at 9.1x EV/EBITDA and 12.8x earnings, the shares pay a sustainable 3.4% dividend yield, the balance sheet is very strong and Cisco holds a key role in the basic plumbing of technology systems even if its growth rate is only modest. BUY
The Coca-Cola Company (KO) – Last week, we moved the shares from Hold to Sell. The shares trade only modestly below their all-time high and have essentially reached our price target. We see little fundamental reason to increase our price target at this point. Our decision to sell is not an indication of any fundamental problems with the company – it is performing quite well – but primarily one of valuation. We would be more than pleased to repurchase the stock if the price fell noticeably.
Since our initial Buy recommendation in November 2020, the shares have produced a 25% total return. SELL
Dow Inc. (DOW) merged with DuPont to create DowDuPont, then split into three companies in 2019 based on product type. The new Dow is the world’s largest producer of ethylene/polyethylene, the most widely used plastics. Investors undervalue Dow’s hefty cash flows and sturdy balance sheet largely due to its uninspiring secular growth traits, its cyclicality and concern that management will squander its resources. The shares are driven by: 1) commodity plastics prices, which are often correlated with oil prices and global growth, along with competitors’ production volumes; 2) volume sold, largely driven by global economic conditions, and 3) ongoing efficiency improvements (a never-ending quest of all commodity companies). We see Dow as having more years of strong profits before capacity increases signal a cyclical peak, and expect the company to continue its strong dividend, reduce its pension and debt obligations, repurchase shares slowly and restrain its capital spending.
There was no significant company-specific news in the past week.
The quarterly dividend appears readily sustainable and provides an appealing 5.4% yield. The shares trade at a low 4.7x EV/EBITDA multiple. Barring a deep recession, collapse in oil prices or a surge in supply, Dow’s fundamental earnings picture seems solid. Dow shares fell 7% in the past week and have 50% upside to our 78 price target. BUY
Merck (MRK) shares are undervalued as investors worry about Keytruda, a blockbuster oncology treatment (about 30% of revenues) that faces generic competition in late 2028. Also, its Januvia diabetes treatment may see generic competition next year, and like all pharmaceuticals, it is at risk from possible government price controls. Yet, Keytruda is an impressive franchise that is growing at a 20% rate and will produce solid cash flow for nearly six more years, providing the company with considerable time to replace the potential revenue loss. Merck’s new CEO, previously the CFO, is accelerating Merck’s acquisition program, which adds return potential and risks to the story. The company is highly profitable and has a solid balance sheet. It spun off its Organon business in June 2021 and we think it will divest its animal health segment sometime in the next five years.
Bloomberg reported that Merck’s talks to acquire biotech giant ($28 billion market cap) Seagen have stalled. We have mixed views of this likely expensive transaction – while it may bring new and promising revenue streams, they come at a high price and limit Merck’s financial flexibility to complete smaller but possibly more appealing deals.
Merck shares fell 3% in the past week and have about 14% upside to our 99 price target. The company has a strong commitment to its dividend (3.2% yield) which it backs up with generous free cash flow, although its shift to a more acquisition-driven strategy will slow the pace of dividend increases. While the shares have pulled back, we are retaining our Hold rating as rising interest rates reduce the upside potential value of its shares. HOLD
State Street Corporation (STT) – Based in Boston, State Street is the world’s largest custodian bank, with $38 trillion in assets under custody/administration. In its early days, State Street provided back-office services for investment managers, including holding securities for safekeeping and processing of investment fund transactions. Over time, the bank added middle-office and front-office services, including client reporting, electronic trading and full enterprise solutions for investment managers. Today, all of these services comprise about 56% of the bank’s revenues.
The industry has consolidated into four dominant firms, including #2 Bank of New York Mellon, JPMorgan and Citigroup, due to the economies of scale that allow larger firms to offer more and better services at lower costs. A recent indicator of these economies is that State Street acquired the back-office operations of Brown Brothers Harriman (BBH), adding $5.4 trillion in assets under custody/administration, as BBH wanted to focus on its core investment management activities.
The bank’s State Street Global Advisors subsidiary is a major issuer of index exchange-traded funds (ETF), with $3.5 trillion in assets under management. SSGA produces about 17% of total revenues. In addition, the bank earns interest income on its portfolio of investments, which contributes about 16% of total revenues. The balance of revenues is produced from foreign currency transactions.
Shares of this well-managed, high-quality bank are out of favor with investors. Since reaching 104 in January, the shares have declined about 30% and are essentially unchanged since 2007. Near-term concerns include the bank’s fee sensitivity to stock and bond markets, cost pressures from wages (about half of total expenses), travel and other expenses, the likely loss of some cash deposits as customers shop around for higher returns on their short-term cash balances, and potential integration issues with the BBH combination. Longer-term concerns include slow industry revenue growth along with steady pricing pressure from competitors.
While we acknowledge these issues, we see State Street as a solid, well-capitalized franchise that provides critical services, with a slow-growth but steady revenue and earnings stream. Our interest in STT shares is that we can buy them at an attractive 8.6x estimated 2023 earnings. This is below what we believe is a fair valuation at about 11x. The valuation on tangible book value (TBV), at about 1.9x, is also at the low end of its post-financial crisis valuation range. We place a more appropriate valuation at about 2.1x TBV based on likely 2023 tangible book value. We also find the dividend yield appealing.
As State Street is a major provider of ESG (Environmental, Social and Governance) focused funds, the rising tide of sentiment against these types of funds could threaten an erosion of State Street’s money management business. In short, many are concerned that there is a hidden political agenda within the ESG movement, and that pension plans that put ESG criteria ahead of total return criteria may be violating their fiduciary duty. We set aside the merits of the arguments on either side in our analysis and estimate that the likely financial impact to State Street and other index ETF providers will be minimal.
State Street shares fell 2% in the past week and have about 36% upside to our 94 price target. The company’s dividend (3.6% yield) is well supported and backed by management’s strong commitment. BUY
Buy Low Opportunities Portfolio
New Buy: Gates Industrial Corp, plc (GTES) – This company is a specialized producer of industrial drive belts and tubing. While this niche might sound unimpressive, Gates has become a leading global manufacturer through innovation. Its customers depend on heavy-duty vehicles, robots, production and warehouse machines and other equipment to operate without fail, so the belts and hydraulic tubing that power these must be exceptionally reliable. And, few buyers would balk at a reasonable price premium on a small-priced part from Gates if it means their million-dollar equipment keeps running. Even in automobiles, which comprise roughly 43% of its revenues, Gates’ belts are nearly industry-standard for their reliability and value. Helping provide revenue stability, over 60% of its sales are for replacements.
Based in Denver, Colorado, Gates was founded in 1911 and was owned by private equity firm Blackstone from 2014 until its IPO in 2018 (Blackstone retains a 63% stake today). Gates was poorly run by its prior owners, but during its Blackstone ownership, the company improved its product lineup and quality, operating efficiency, culture and financial performance. Today, its 20% EBITDA margin is on par with or above its larger and more diversified peers. It is well-positioned to prosper in an electric vehicle world, as its average content per EV, which require water pumps and other thermal management components for the battery and inverters, is likely to be considerably higher than its average content per gas-powered vehicle. The management and board are high quality, which helps it follow a disciplined operating and capital allocation strategy. Gates’ debt balance has been reduced to a reasonable level, with considerable support from robust free cash flow.
Near-term results continue to be pressured by sluggish sales in China (12% of revenues) and ongoing disruption to its supply of key raw materials. We see these problems fading over time.
Investor concerns over Gates’ near-term issues and macro headwinds have driven the shares down 40% from their late 2021 high, to nearly 45% below the 2018 IPO price of $19. The modest 7.2x EV/EBITDA significantly undervalues the company’s long-term fundamental strength. We are starting shares of Gates Industrial Corp (GTES) with a Buy and a $14 price target, approximately 30% above the current price. BUY
Allison Transmission Holdings, Inc. (ALSN) – Allison Transmission is a midcap ($6.4 billion market cap) manufacturer of vehicle transmissions. Many investors view this company as a low-margin producer of car and light truck transmissions that is destined for obscurity in an electric vehicle world. However, Allison produces no car and light truck transmissions, instead, it focuses on the school bus and Class 6-8 heavy-duty truck categories, where it holds an 80% market share. Its 35% EBITDA margin is sharply higher than its competitors and on par with many specialty manufacturers. And, it is a leading producer and innovator in electric axles which all-electric trucks will require. Another indicator of its advanced capabilities: Allison was selected to help design the U.S. Army’s next-generation electric-powered vehicle. The company generates considerable free cash flow and has a low-debt balance sheet. Its capable leadership team keeps its shareholders in mind, as the company has reduced its share count by 38% in the past five years.
There was no significant company-specific news in the past week.
Allison shares fell 1% in the past week and have 30% upside to our 48 price target. The stock pays an attractive and sustainable 2.3% dividend yield to help compensate investors while waiting for the recovery. BUY
Arcos Dorados (ARCO), which is Spanish for “golden arches,” is the world’s largest independent McDonald’s franchisee. Based in stable Uruguay and listed on the NYSE, the company produces about 72% of its revenues in Brazil, Mexico, Argentina and Chile. The shares are depressed as investors worry about the pandemic, as well as political/social unrest, inflation and currency devaluations. However, the company has a solid brand and high recurring demand and is well-positioned to benefit as local economies reopen. The leadership looks highly capable, led by the founder/chairman who owns a 38% stake, and has the experience to successfully navigate the complex local conditions. Debt is reasonable relative to post-recovery earnings, and the company is currently producing positive free cash flow.
Macro issues, including issues in Brazil related to its economic conditions (in particular, inflation, running at an 11.7% rate), currency and the chances that a socialist might win this year’s Brazilian presidential elections, will continue to influence ARCO shares.
There was no significant company-specific news in the past week.
ARCO shares rose 1% in a difficult market this past week and have 13% upside to our 8.50 price target. The ongoing rebound appears to be some recognition that the sell-off following the earnings report was not warranted. BUY
Aviva, plc (AVVIY), based in London, is a major European company specializing in life insurance, savings and investment management products. Amanda Blanc was hired as the new CEO in July 2020 to revitalize Aviva’s laggard prospects. She divested operations around the world to re-focus the company on its core geographic markets (U.K., Ireland, Canada) and is improving Aviva’s product competitiveness, rebuilding its financial strength and trimming its bloated costs. Aviva’s dividend has been reduced to a more predictable and sustainable level with a modest upward trajectory. Excess cash balances are being directed toward debt reduction and potentially sizeable special dividends and share repurchases.
Much of our interest in Aviva is based on its plans for returning its excess capital to shareholders, including share repurchases and dividends. These distributions could be substantial. We also look for incremental shareholder-friendly pressure from highly regarded European activist investor Cevian Capital, which holds a 5.2% stake.
There was no significant company-specific news in the past week.
Aviva shares fell 4% in the past week and have about 45% upside to our 14 price target. Based on management’s estimated dividend for 2023 (which we believe is highly credible), the shares offer a generous 8.6% yield. Based on this year’s actual dividend, the shares offer an attractive 5.8% dividend yield. BUY
Barrick Gold (GOLD), based in Toronto, is one of the world’s largest and highest-quality gold mining companies. About 50% of its production comes from North America, with the balance from Africa/Middle East (32%) and Latin America/Asia Pacific (18%). Barrick will continue to improve its operating performance (led by its new and highly capable CEO), generate strong free cash flow at current gold prices, and return much of that free cash flow to investors while making minor but sensible acquisitions. Also, Barrick shares offer optionality – if the unusual economic and fiscal conditions drive up the price of gold, Barrick’s shares will rise with it. Given their attractive valuation, the shares don’t need this second (optionality) point to work – it offers extra upside. Barrick’s balance sheet has nearly zero debt net of cash. Major risks include the possibility of a decline in gold prices, production problems at its mines, a major acquisition and/or an expropriation of one or more of its mines.
There was no significant company-specific news in the past week.
Over the past week, commodity gold ticked down 2% to $1,737/ounce. Both the dollar and interest rates continue to move upward, and inflation worries seem to be receding, all of which are weighing on the price of commodity gold, and hence Barrick’s share price. Investing in gold-related equities is a long-term decision – investors shouldn’t allow near-term weakness to deter their resolve.
The 10-year Treasury yield rose to 3.13%. The U.S. Dollar Index, another driver of gold prices (the dollar and gold usually move in opposite directions), resumed its drive upward, reaching 108.82, a 20-year high. The dollar index peaked in July 2001 at about 121 – a level not entirely out of reach in this cycle but one that would further pressure already-strained emerging and other countries.
Barrick shares fell 8% in the past week and have about 81% upside to our 27 price target. Our resolve with Barrick shares remains undaunted through the recent selloff. BUY
Big Lots (BIG) – Big Lots is a discount general merchandise retailer based in Columbus, Ohio, with 1,431 stores across 47 states. Its stores offer an assortment of furniture, hard and soft home goods, apparel, electronics, food and consumables as well as seasonal merchandise. Our bullish case for Big Lots rests with its loyal and growing base of 22 million rewards members, its appeal to bargain-seeking customers, the relatively stable (albeit low) 5.5% cash operating profit margin, its positive free cash flow, debt-free balance sheet and low share valuation at 3.1x EV/EBITDA and 7.3x per-share earnings based on conservative January 2023 estimates.
Our thesis was deeply rattled by the company’s dismal first-quarter results. Offloading its bloated inventory will require sharp discounts, which will weigh on profits while the $271 million in new borrowing ramps up the risk. We are retaining our HOLD rating for now: investor expectations are sufficiently depressed to provide some downside cushion, while management should be able to extract itself from the worst of the inventory problem over the next few quarters. Nevertheless, the Big Lots investment is now high-risk due to the new debt balance, the lost value from the inventory glut and the likelihood of a suspension of the dividend.
Big Lots reported a second-quarter adjusted net loss of $(2.28)/share, compared to an adjusted profit of $2.75 a year ago and estimates for a $(2.47) loss. Revenues of $1.35 billion fell 8% but were fractionally higher than estimates. While the results were awful and the company is struggling with bulging inventories in a difficult retail and economic environment, its results were better than the dour expectations. The relatively favorable news, plus covering by short-trading investors, lifted the shares in mid-day trading on Tuesday.
Slowing economic conditions and weaker pricing weighed on sales. These factors drove comparable store sales down 9.2% in the quarter. On weaker sales combined with elevated discounting, the gross margin fell to 32.6% from 39.6% a year ago. All-in, gross profits fell $139 million from a year ago. This accounted for the entire decline in operating profits, as overhead costs were essentially unchanged. We view this as somewhat encouraging – once the company offloads its bloated inventory, profits should rebound.
However, how much profits rebound is an open question. There is of course no guarantee that this inventory will sell at respectable prices. The company guided for inventories to be under control by the end of the next quarter. This should help set them up for a respectable holiday season.
Big Lots’ balance sheet remains stressed. Cash is $49 million, down from $292 million a year ago. The company announced that it will pay its next dividend, but we see this as perhaps the last one for a while. Also, the company is working to update its borrowing programs, a clear positive in our view.
Despite the company’s frustrating fundamentals, we are retaining our Hold rating on the shares.
Big Lots shares fell 1% this past week, supported by a jump on the relatively positive earnings report, and have 50% upside to our $35 price target. The shares offer a 5.1% dividend yield, although, as noted, investors should not rely on this dividend being sustained. HOLD
Citigroup (C) – Citi is one of the world’s largest banks, with over $2.4 trillion in assets. The bank’s weak compliance and risk-management culture led to Citi’s disastrous and humiliating experience in the 2009 global financial crisis, which required an enormous government bailout. The successor CEO, Michael Corbat, navigated the bank through the post-crisis period to a position of reasonable stability. Unfinished, though, is the project to restore Citi to a highly profitable banking company, which is the task of new CEO Jane Fraser.
This past week, the yield spread between the 90-day T-bill and the 10-year Treasury note, which approximates the drivers behind Citi’s net interest margin, remained unchanged at 0.26%.
A recession would likely increase Citi’s credit losses, a flatter yield curve would weigh on its net interest margin, and weaker capital markets would mean fewer investment banking revenues. However, a recession and tighter capital markets would likely weed out some competitors like buy-now-pay-later companies, crypto payment services and digital-only banks. Also, tech talent may become more available at reasonable wages and potential technology company acquisition targets would likely be cheaper. Citi might emerge from a recession even stronger.
There was no significant company-specific news in the past week.
Citi shares trade at 64% of tangible book value. This immense discount, which assumes a dim future for Citi, appears to be misplaced. For comparison, beleaguered Credit Suisse, which faces potential collapse, trades at 30% of tangible book value. One could accurately say that Citi is more than 2x as healthy as Credit Suisse.
Citi shares fell 4% in the past week and about 73% upside to our 85 price target. Citigroup investors enjoy a 4.2% dividend yield and perhaps another 3% or more in annual accretion from the bank’s share repurchase program once it reaches its new target capital ratio and if a slowing/stalling economy doesn’t meaningfully increase its credit costs. BUY
Molson Coors Beverage Company (TAP) is one of the world’s largest beverage companies, producing the highly recognized Coors, Molson, Miller and Blue Moon brands as well as numerous local, craft and specialty beers. About two-thirds of its revenues come from the United States, where it holds a 24% market share. Investors worry about Molson Coors’ lack of revenue growth due to its relatively limited offerings of fast-growing hard seltzers and other trendier beverages. Our thesis for this company is straightforward – a reasonably stable company whose shares sell at an overly discounted price. Its revenues are resilient, it produces generous cash flow and is reducing its debt. A new CEO is helping improve its operating efficiency and expand carefully into more growthier products. The company recently reinstated its dividend.
There was no significant company-specific news in the past week.
TAP shares fell 5% in the past week and have about 30% upside to our 69 price target. The stock remains cheap, particularly on an EV/EBITDA basis, or enterprise value/cash operating profits, where it trades at 8.8x estimated 2022 results, still among the lowest valuations in the consumer staples group and below other brewing companies. The 2.9% dividend yield only adds to the appeal. BUY
Organon & Company (OGN) was recently spun off from Merck. It specializes in patented women’s healthcare products and biosimilars, and also has a portfolio of mostly off-patent treatments. Organon will produce better internal growth with some boost through smart yet modest-sized acquisitions. It may eventually divest its Established Brands segment. The management and board appear capable, the company produces robust free cash flow, has modestly elevated debt and will pay a reasonable dividend. Investors have ignored the company, but we believe that Organon will produce at least stable and large free cash flows with a reasonable potential for growth. At our initial recommendation, the stock traded at a highly attractive 4x earnings.
There was no significant company-specific news in the past week.
OGN shares slipped 4% in the past week and have about 59% upside to our 46 price target (using the same target as the Cabot Turnaround Letter). The shares continue to trade at a remarkably low valuation while offering an attractive 3.9% dividend yield. BUY
Sensata Technologies (ST) is a $3.8 billion (revenues) producer of nearly 47,000 highly engineered sensors used by automotive (60% of revenues), heavy vehicle, industrial and aerospace customers. About two-thirds of its revenues are generated outside of the United States, with China producing about 21%. Investors undervalue Sensata’s durable franchise. Its sensors are typically critical components that generally produce high profit margins. As the sensors’ reliability is vital to safety and performance, customers are reluctant to switch to another supplier that may have lower prices but also lower or unproven quality. Sensata has an arguably under-leveraged balance sheet and generates healthy free cash flow. The relatively new CEO will likely continue to expand the company’s growth potential through acquisitions. Electric vehicles are an opportunity as they expand Sensata’s reachable market.
Overall, the Sensata investment remains sharply underwater as its revenue growth is challenged by new economic cycle pressures on top of the post-pandemic supply chain issues. The company is well-positioned for the post-recession, electric vehicle environment, but investors will have to wait for perhaps a year for that to arrive. The shares are still worth holding onto given their now-low valuation and ability to financially endure the downturn.
There was no significant company-specific news in the past week.
ST shares declined 4% in the past week and have about 84% upside to our 75 price target. Our price target looks optimistic in light of the broad market selloff, but we will keep it for now, even as it may take longer for the shares to reach it. BUY
Disclosure:The chief analyst of the Cabot Undervalued Stocks Advisor personally holds shares of every recommended security, except for “New Buy” recommendations. The chief analyst may purchase or sell recommended securities but not before the fourth day after any changes in recommendation ratings has been emailed to subscribers. “New Buy” recommendations will be purchased by the chief analyst as soon as practical following the fourth day after the newsletter issue has been emailed to subscribers.
| Growth/Income Portfolio | |||||||
| Stock (Symbol) | Date Added | Price Added | 8/31/22 | Capital Gain/Loss | Current Dividend Yield | Price Target | Rating |
| Cisco Systems (CSCO) | 11-18-20 | 41.32 | 45.24 | 9.5% | 3.4% | 66.00 | Buy |
| Coca-Cola (KO) | 11-11-20 | 53.58 | 62.15 | 16.0% | 2.7% | 69.00 | SELL |
| Dow Inc (DOW) * | 04-01-19 | 53.50 | 51.38 | -4.0% | 5.4% | 78.00 | Buy |
| Merck (MRK) | 12-9-20 | 83.47 | 86.88 | 4.1% | 3.2% | 99.00 | Hold |
| State Street Corp (STT) | 8-19-22 | 74.53 | 69.08 | -7.3% | 3.6% | 94.00 | Buy |
| Buy Low Opportunities Portfolio | |||||||
| Stock (Symbol) | Date Added | Price Added | 8/31/22 | Capital Gain/Loss | Current Dividend Yield | Price Target | Rating |
| Allison Transmission Hldgs (ALSN) | 02-22-22 | 39.99 | 36.73 | -8.2% | 2.3% | 48.00 | Buy |
| Arcos Dorados (ARCO) | 04-28-21 | 5.41 | 7.39 | 36.6% | 2.2% | 8.50 | Buy |
| Aviva (AVVIY) | 03-03-21 | 10.75 | 9.62 | -10.5% | 5.8% | 14.00 | Buy |
| Barrick Gold (GOLD) | 03-17-21 | 21.13 | 14.99 | -29.1% | 2.7% | 27.00 | Buy |
| Gates Industrial Corp (GTES) | 08-31-21 | 10.74 | 10.84 | 0.9% | 0.0% | 14.00 | New Buy |
| BigLots (BIG) | 04-12-22 | 35.24 | 24.08 | -31.7% | 5.0% | 35.00 | Hold |
| Citigroup (C) | 11-23-21 | 68.10 | 49.08 | -27.9% | 4.2% | 85.00 | Buy |
| Molson Coors (TAP) | 08-05-20 | 36.53 | 52.25 | 43.0% | 2.9% | 69.00 | Buy |
| Organon (OGN) | 06-07-21 | 31.42 | 28.66 | -8.8% | 3.9% | 46.00 | Buy |
| Sensata Technologies (ST) | 02-17-21 | 58.57 | 40.65 | -30.6% | 1.1% | 75.00 | Buy |
*Note: DOW price is based on April 1, 2019 closing price following spin-off from DWDP.
Buy – This stock is worth buying.
Strong Buy – This stock offers an unusually favorable risk/reward trade-off, often one that has been rated as a Buy yet the market has sold aggressively for temporary reasons. We recommend adding to existing positions.
Hold – The shares are worth keeping but the risk/return trade-off is not favorable enough for more buying nor unfavorable enough to warrant selling.
Sell – This stock is approaching or has reached our price target, its value has become permanently impaired or changes in its risk or other traits warrant a sale.
Note for stock table: For stocks rated Sell, the current price is the sell date price.
| CUSA Valuation and Earnings | |||||||
| Growth/Income Portfolio | |||||||
| Current price | Current 2022 EPS Estimate | Current 2023 EPS Estimate | Change in 2022 Estimate | Change in 2023 Estimate | P/E 2022 | P/E 2023 | |
| CSCO | 45.20 | 3.53 | 3.81 | 0.0% | 0.0% | 12.8 | 11.9 |
| KO | 62.52 | 2.46 | 2.61 | 0.0% | 0.0% | 25.4 | 24.0 |
| DOW | 51.90 | 7.98 | 6.62 | -0.4% | -0.3% | 6.5 | 7.8 |
| MRK | 87.08 | 7.37 | 7.46 | 0.0% | 0.0% | 11.8 | 11.7 |
| STT | 69.13 | 7.12 | 8.55 | 0.0% | 0.0% | 9.7 | 8.1 |
| Buy Low Opportunities Portfolio | |||||||
| Current price | Current 2022 EPS Estimate | Current 2023 EPS Estimate | Change in 2022 Estimate | Change in 2023 Estimate | P/E 2022 | P/E 2023 | |
| ALSN | 36.96 | 5.75 | 6.68 | 0.0% | 0.0% | 6.4 | 5.5 |
| ARCO | 7.55 | 0.46 | 0.55 | 0.0% | 0.0% | 16.4 | 13.7 |
| AVVIY | 9.67 | 1.06 | 1.32 | -2.2% | 0.0% | 9.2 | 7.3 |
| GOLD | 14.88 | 1.03 | 1.06 | 0.0% | 0.0% | 14.4 | 14.0 |
| GTES | 10.71 | 1.22 | 1.32 | na | na | 8.8 | 8.1 |
| BIG | 23.37 | (2.80) | 1.76 | 15.2% | -22.1% | (8.3) | 13.3 |
| C | 49.08 | 7.29 | 7.18 | 0.0% | 0.0% | 6.7 | 6.8 |
| TAP | 52.99 | 3.94 | 4.19 | 0.0% | 0.0% | 13.4 | 12.6 |
| OGN | 28.85 | 4.97 | 5.47 | 0.0% | 0.0% | 5.8 | 5.3 |
| ST | 40.76 | 3.40 | 4.00 | 0.0% | 0.0% | 12.0 | 10.2 |
Current price is yesterday’s mid-day price.
CSCO: Estimates are for fiscal years ending in July.